Article By: Alex Stenzler Respiratory Therapy Vol. 18 No. 4 Fall 2023 In this feature, Respiratory Therapy interviews clinicians and healthcare providers about the actual application of specific products and therapies. This interview is with Alex Stenzler, the Chief Science Officer of Monitored Therapeutics (MTI), a remote health monitoring company. He is also the President […]
By: Jane Turner1,2, Qianchuan He3, Kelsey Baker1, Lisa Chung4, Adrian Lazarevic-Fogelquist5, Danika Bethune5, Jesse Hubbard1, Margaret Guerriero6, Ajay Sheshadri7, Karen L. Syrjala1,8, Paul J. Martin1,9, Michael Boeckh1,4,10, Stephanie J. Lee1,9, Ted Gooley1, Mary E. Flowers1,9, Guang-Shing Cheng1,6,* 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 2 Division of Respirology, McMaster University, Hamilton, […]
By: Ajay Sheshadri1*, MSc, MD; Sukh Makhnoon2*, MSc, PhD; Amin M Alousi3, MD; Lara Bashoura1, MD; Rene Andrade2, BS; Christopher J Miller2, MPH; Karen R Stolar3, MS; Muhammad Hasan Arain1, MBBS; Laila Noor1, MBBS; Amulya Balagani1, MD; Akash Jain1, MD; David Blanco1, RPFT; Abel Ortiz1, CRT; Michael S Taylor4, BS; Alex Stenzler4, MD; Rohtesh Mehta3, […]
By: Ajay Sheshadri1, Amin Alousi2, Lara Bashoura1, Karen Stolar2, Shiva Baghaie1, Muhammad H. Arain1, Laila Noor1, Amulya Balagani1, Akash Jain1, David Blanco1, Abel Ortiz1, Susan K. Peterson3, Renee Langhals4, Michael Taylor4, Alex Stenzler4, Rohtesh S. Mehta2, Uday R. Popat2, Chitra Hosing2, Gabriela Rondon2, Fan Shen4, Liang Li4, Guang-Shing Cheng6, David E. Ost1, Richard E. Champlin2, […]
Article by : Christopher B Cooper, Worawan Sirichana, Eric V Neufeld, Michael Taylor, Xiaoyan Wang, Brett A Dolezal. Background: COPD exacerbations occur more frequently with disease progression and are associated with worse prognosis and higher healthcare expenditure. Purpose: To utilize a networked system, optimized with statistical process control (SPC), for remote patient monitoring (RPM) and […]
Article By: Alex Stenzler Respiratory Therapy Vol. 14 No. 4 n Fall 2019 Introduction Chronic Obstructive Pulmonary Disease (COPD) is a group of progressive lung diseases that obstruct airflow. It is the third leading cause of death in the United States, affecting 16 million Americans and millions more who are not aware they have the […]
Article By: Alex Stenzler, Martin Stegenga The gold standard considered by almost everyone who performs Forced Vital Capacity (FVC) spirometry measurements is, “Does the spirometer meet the ATS/ERS guidelines, and has it passed the 24 waveform tests the Task Force created in 1994”.1,2,3 Overwhelmingly, manufacturers tout their FDA clearance and the passing of the 24 […]
Article by : Christopher B Cooper, Worawan Sirichana, Eric V Neufeld, Michael Taylor, Xiaoyan Wang, Brett A Dolezal. Background: Exacerbations of chronic obstructive pulmonary disease (COPD) occur with increasing frequency as the disease progresses and account for poor health status, worse prognosis, and higher healthcare expenditure. Methods: We developed a networked system for remote physiological […]
By: Kevin McCarthy Monitoring Spirometry at Home The last several years have seen a large increase in the interest in telehealthcare. Some of this interest is driven by the lower costs of managing patients in their homes; some by the recent implementation of penalties for rehospitalization of patients after hospital discharge; and some driven by […]
Alex Stenzler The focus of this editorial may seem counter-intuitive to many. Chronic Obstructive Pulmonary Disease (COPD) is by definition a disease that obstructs the airways, which seems best monitored by frequent measurements of airflow obstruction. The tool that has been the mainstay of monitoring COPD patients at home is a spirometer and its measurements […]